From the Research
The recommended dose of dexamethasone for fetal lung maturity in a mother at risk of preterm delivery is 5 mg intramuscularly given every 12 hours for a total of four doses (20 mg total). This regimen should be administered between 24 and 34 weeks of gestation when preterm delivery is anticipated. For optimal benefit, delivery should ideally be delayed until at least 24 hours after the first dose, with maximum benefit occurring when the complete course is given 48 hours to 7 days before delivery. Dexamethasone works by accelerating fetal lung development, specifically increasing surfactant production, which reduces the risk of respiratory distress syndrome in the newborn. This treatment also provides additional benefits including decreased risks of intraventricular hemorrhage, necrotizing enterocolitis, and neonatal death. If preterm delivery doesn't occur within 7 days and gestational age is still less than 34 weeks, a repeat course may be considered, though this should be discussed with a specialist as multiple courses have potential risks.
The most recent and highest quality study, 1, supports the use of a 5-mg dose of dexamethasone, which was found to be noninferior to the standard 6-mg dose in preventing neonatal respiratory distress syndrome in preterm births. This study, published in 2024, provides the most up-to-date evidence on the optimal dose of dexamethasone for fetal lung maturity.
Key points to consider:
- The dose of 5 mg intramuscularly given every 12 hours for a total of four doses (20 mg total) is recommended based on the most recent and highest quality study 1.
- The treatment should be administered between 24 and 34 weeks of gestation when preterm delivery is anticipated.
- Delivery should ideally be delayed until at least 24 hours after the first dose, with maximum benefit occurring when the complete course is given 48 hours to 7 days before delivery.
- Dexamethasone works by accelerating fetal lung development, specifically increasing surfactant production, which reduces the risk of respiratory distress syndrome in the newborn.
- Additional benefits of dexamethasone treatment include decreased risks of intraventricular hemorrhage, necrotizing enterocolitis, and neonatal death.